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Summary
Pregnancy-associated malaria (PAM) is caused by
Plasmodium falciparum-infected erythrocytes (IEs)
that bind to chondroitin sulphate A (CSA) in the pla-
centa by PAM-associated clonally variant surface anti-
gens (VSA). Pregnancy-speciﬁc VSA (VSAPAM), which
include the PfEMP1 variant VAR2CSA, are targets of
IgG-mediated protective immunity to PAM. Here, we
report an investigation of the speciﬁcity of naturally
acquired immunity to PAM, using eight human mono-
clonal IgG1 antibodies that react exclusively with
intact CSA-adhering IEs expressing VSAPAM. Four
reacted in Western blotting with high-molecular-
weight (> 200 kDa) proteins, while seven reacted with
either the DBL3-X or the DBL5-e domains of VAR2CSA
expressed either as Baculovirus constructs or on the
surface of transfected Jurkat cells. We used a panel of
recombinant antigens representing DBL3-X domains
from P. falciparum ﬁeld isolates to evaluate B-cell
epitope diversity among parasite isolates, and identi-
ﬁedthebindingsiteofonemonoclonalantibodyusing
a chimeric DBL3-X construct. Our ﬁndings show that
thereisahigh-frequencymemoryresponsetoVSAPAM,
indicating that VAR2CSA is a primary target of natu-
rally acquired PAM-speciﬁc protective immunity, and
demonstrate the value of human monoclonal antibod-
ies and conformationally intact recombinant antigens
in VSA characterization.
Introduction
People living in areas of intense transmission of Plasmo-
dium falciparum parasites acquire protective immunity to
malaria during childhood, and the bulk of mortality and
severe morbidity from P. falciparum malaria is therefore
concentrated among young children. Protective immunity
acquired in response to P. falciparum exposure appears
to be mediated mainly by IgG antibodies speciﬁc for
variant surface antigens (VSA) that mediate sequestration
of infected erythrocytes (IEs) in various tissues (reviewed
by Hviid, 2005). Despite pre-existing protective immunity,
women become highly susceptible to P. falciparum
infection when they become pregnant, and pregnancy-
associated malaria (PAM) is a major cause of mother/
offspring morbidity (Guyatt and Snow, 2001; 2004).
However, in areas of stable P. falciparum transmission,
susceptibility to PAM rapidly declines with increasing
parity, consistent with acquisition of PAM-speciﬁc protec-
tive immunity (reviewed by Hviid, 2004). PAM is caused
by P. falciparum-IEs selectively accumulating in the pla-
cental intervillous space through VSAPAM-mediated adhe-
sion to chondroitin sulphate A (CSA). VSAPAM differ in
several ways from VSA expressed on IEs obtained from
males and non-pregnant females. Thus, only VSAPAM
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and only VSAPAM-expressing IEs are consistently not rec-
ognized by IgG in the plasma of P. falciparum-exposed
women who have never been pregnant or by IgG in
plasma from similarly exposed men (Beeson et al., 1999;
Ricke et al., 2000). These observations, and the fact that
plasma levels of VSAPAM-speciﬁc IgG increase with
increasing parity (Fried et al., 1998; Ricke et al., 2000),
are consistent with evidence that these antibodies are the
mediators of protective immunity to PAM (Duffy and Fried,
2003; Staalsoe et al., 2004).
The molecular identity of VSAPAM remains controversial,
although current evidence points to VAR2CSA, an inter-
clonally conserved member of the PfEMP1 molecules
encoded by the multigene var family. Thus, transcription
of the gene encoding VAR2CSAis increased among CSA-
adhering and placental isolates, VAR2CSA is exposed on
the surface of CSA-adhering IEs (Salanti et al., 2003;
2004; Tuikue Ndam et al., 2005), and plasma levels of
VAR2CSA-speciﬁc IgG increase with increasing parity
and correlate with protective immunity to PAM (Salanti
et al., 2004). However, the importance of VAR2CSA-
speciﬁc antibodies relative to antibodies speciﬁc for other
putative VSAPAM in acquired protective immunity to PAM
remains to be established. The clonal analysis of memory
B cells represents a powerful tool to dissect the immune
response to complex pathogens such as P. falciparum
(Lanzavecchia et al., 2006). In this study, we used an
improved Epstein–Barr virus (EBV) immortalization
method (Traggiai et al., 2004) to analyse memory B cells
from multiparous PAM-exposed women. Frequency
analysis and isolation of speciﬁc monoclonal antibodies
identiﬁed polymorphic, linear and conformation-
dependent epitopes in VAR2CSA as dominant targets of
the human memory B-cell response to PAM.
Results and discussion
PAM induces a high-frequency VSAPAM-speciﬁc memory
B-cell response
We ﬁrst used ﬂow cytometry to screen plasma from 27
PAM-exposed and recently pregnant multigravidae for IgG
antibodies capable of staining P. falciparum-IEs express-
ing VSAPAM (Staalsoe et al., 1999; Ricke et al., 2000). We
selected three donors (one parity 2 and two parity 3
women) with high VSAPAM-speciﬁc plasma antibody levels
and used frozen peripheral blood mononuclear cells
(PBMC) obtained 1 month post-partum. Memory B cells
were immortalized with EBV in the presence of CpG oligo-
nucleotides and allogeneic, irradiated PBMC as described
(Traggiai et al., 2004). A total of 5760 replicate cultures of
100 immortalized B cells per well were set up, and after
3 weeks the culture supernatants were screened for their
capacity to stain erythrocytes infected with each of three
P. falciparumlines.Twoofthelines(FCR3-CSAandNF54-
VAR2CSA) had been previously selected in vitro to
express VSAPAM, characterized by reactivity with IgG from
multiparous women and lack of reactivity with IgG from
P. falciparum-exposed men (Fig. 1) (Fried et al., 1998;
Beeson et al., 1999; Ricke et al., 2000). The third line
(3D7-SM) was selected to express non-PAM-type VSA
equally recognized by IgG from P. falciparum-exposed
men and women (Fig. 1) (Staalsoe et al., 2003; Jensen
et al., 2004). Supernatants from 105 of the polyclonal
B-cell lines stained one or both of the VSAPAM-expressing
lines. The frequency of VSAPAM-reactive polyclonal super-
natants varied from 6/1920 [0.3% (95% conﬁdence inter-
val: 0.1–0.7%)] to 33/1344 [2.5% (1.8–3.4%)] in the three
donors. These results suggest that the frequency of
VSAPAM-speciﬁcBcellscanbehigh(atleastupto1in4000
memory B cells) in recently pregnant multigravidae. The
higher memory B-cell frequencies in the present study
compared with earlier reports for PfEMP1 (Dorfman et al.,
2005) and total P. falciparum antigens (Fievet et al., 1993;
Migot et al., 1995) probably reﬂect the efficient method of
B-cell immortalization employed here.
VSAPAM-speciﬁc human monoclonal IgG1 antibodies
speciﬁcally recognize polymorphic epitopes on IEs
selected for adhesion to CSA
Cloning of EBV-immortalized IgG+ B cells from 28 of the
VSAPAM-speciﬁc lines by limiting dilution resulted in eight
clones producing VSAPAM-speciﬁc IgG1. Lines were
selected for cloning on the basis of their IgG synthesis
Fig. 1. Flow cytometry analysis of human VSA-speciﬁc plasma IgG
reactivity with the surface of P. falciparum-IEs. Labelling of
FCR3-CSA, NF54-VAR2CSA and 3D7-SM by IgG in individual
plasma samples from P. falciparum-exposed pregnant women (),
from sympatric men () and from non-exposed adult control donors
() are shown.
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PAM2.8, PAM3.10, PAM5.2, PAM6.1, PAM7.5) produced
antibodies recognizing antigens on the surface of eryth-
rocytes infected by both the VSAPAM-expressing lines
used to screen for antibody speciﬁcity (Table 1). Antibod-
ies from the two remaining clones (PAM4.7 and PAM8.1)
only recognized FCR3-CSA. In contrast, none of the
monoclonal antibodies recognized the 3D7-SM control
line not expressing VSAPAM (Fig. 2A–C). Testing of mono-
clonal antibody reactivity with erythrocytes infected by a
panel of additional parasite lines provided further evi-
dence that all were indeed speciﬁc for PAM-type VSA
expressed on the surface of CSA-adhering IEs (Table 1).
However, the monoclonal antibodies did not all recognize
all VSAPAM-expressing lines, probably because the
epitopes they recognize are polymorphic. IgG antibodies
produced by a control B-cell clone (D7) did not recognize
any of the tested parasite lines. Monoclonal antibody rec-
ognition patterns for individual parasite lines were tested
in parallel, and repeated assessments of recognition pat-
terns yielded consistent results.
The ﬂow cytometry evidence of antibody reactivity with
antigens on the surface of IEs expressing VSAPAM and the
absence of reactivity with non-PAM-type VSA (Table 1)
was conﬁrmed by immunoﬂuorescence microscopy of live
IEs (Fig. 2D and E). Denaturing Western blots of the
VSAPAM-expressing sublines yielded single, distinct bands
(of similar size for each antibody) when probed with
PAM3.10, PAM5.2, PAM6.1 and PAM7.5 monoclonal anti-
bodies (Fig. 2F, and data not shown). Proteins were not
detected when blots were probed with the monoclonal
antibodies PAM1.4, PAM2.8 or PAM4.7 (data not shown)
despite their reactivity with the surface of intact VSAPAM-
expressing IEs (Table 1), pointing to reactivity with
conformation-dependent epitopes. No bands were
observed when the monoclonal antibodies were used to
probe Western blots of the non-PAM-type VSA-
expressing parental lines (Fig. 2F, and data not shown).
PAM8.1 was not tested by Western blotting with IEs
expressing VSAPAM, but was tested with VAR2CSA-
speciﬁc constructs (see below).
VAR2CSA is a dominant target of the human immune
response to pregnancy-associated malaria
The high molecular weight of the proteins detected by
Western blotting (Fig. 2F) suggested that the monoclonal
antibodies were speciﬁc for members of the so far best-
characterized family of VSA, PfEMP1 (Leech et al., 1984).
This family includes VAR2CSA (predicted molecular
weight: 355 kDa), which is the only PfEMP1 described so
far that has the characteristics expected of VSAPAM
(Salanti et al., 2003; 2004). We therefore used a panel of
recombinant proteins spanning the entire extracellular
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shown) to examine the antigen speciﬁcity of the mono-
clonal VSAPAM-speciﬁc IgG antibodies further. Antibodies
PAM2.8, PAM3.10, PAM5.2, PAM6.1 and PAM7.5 tested
positive in 3D7-VAR2CSAdomain-speciﬁc ELISA(Fig. 3A
and Table 2), while antibodies PAM2.8, PAM3.10,
PAM4.7, PAM5.2 and PAM8.1 tested positive in the
FCR3-VAR2CSA ELISA (Table 2). Control ELISA employ-
ing scrambled constructs and constructs from other
PfEMP1 not implicated in the pathogenesis of PAM were
consistently completely negative (data not shown).
VAR2CSA constructs produced in Escherichia coli cells
that should promote disulphide bond formation in
secreted proteins (Barfod et al., 2006) were also consis-
tently negative in ELISA (data not shown). Each of the
VAR2CSA-reactive monoclonal antibodies had absolute
speciﬁcity for either DBL3-X (PAM2.8, PAM6.1 and
PAM8.1; originating from two donors) or DBL5-e
ABC
DEF
Fig. 2. Reactivity of human IgG monoclonal antibodies with P. falciparum-IEs.
A. Labelling of FCR3-CSA, NF54-VAR2CSA and 3D7-SM by VSAPAM-speciﬁc monoclonal antibodies () or an irrelevant control monoclonal
antibody (–), determined by ﬂow cytometry.
B. Reactivity of monoclonal antibody PAM3.10 (heavy line) and an irrelevant control monoclonal antibody (thin line) with the surface of
erythrocytes infected by FCR3-CSA.
C. PAM3.10 reactivity with the surface of erythrocytes infected by unselected FCR3.
D. Immunoﬂuorescence microscopy of FCR3-CSA-infected erythrocytes labelled with PAM3.10 (top) or an irrelevant control antibody (bottom).
E. Immunoﬂuorescence microscopy of unselected FCR3-IEs labelled with PAM3.10 (top) or an irrelevant control antibody (bottom).
F. Reactivity of PAM3.10 in Western blots of FCR3-CSA (left) and FCR3 (centre). Broad-range molecular weight markers are shown in the
right lane.
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BC
Fig. 3. Reactivity of human VSAPAM-speciﬁc IgG1 monoclonal antibodies with VAR2CSA.
A. The top panel shows a schematic representation of VAR2CSA with the positions of the recombinant protein constructs used (A–Z) and the
amino acid numbers indicated along the bottom. Recognition of constructs A, E, I, L, P, T and Z in ELISA, and ﬂow cytometric recognition of
Jurkat cells transfected to express constructs B–D, F–H, J, K, M–O, Q–S, U–Y by antibodies PAM2.8 (red), PAM3.10 (orange), PAM5.2 and
PAM7.5 (green), and PAM6.1 (blue) are shown.
B. PAM6.1-speciﬁc competition ELISA to determine domain speciﬁcity of DBL3-X-reactive IgG (competitors shown in the ﬁgure).
C. PAM3.10-speciﬁc competition ELISA to determine domain speciﬁcity of DBL5-e-reactive IgG (competitors shown in the ﬁgure).
Table 2. Domain speciﬁcity of human VAR2CSA-speciﬁc IgG1 monoclonal antibodies, determined by ELISA.
Parasite Domain
Monoclonal antibody
PAM1.4 PAM2.8 PAM3.10 PAM4.7 PAM5.2 PAM6.1 PAM7.5 PAM8.1
3D7 DBL3-X – + –– – + ––
DBL5-e ––+ – + – + –
FCR3 DBL3-X – + –– – – – +
DBL5-e ––++ + – n.d. –
n.d., not determined.
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from two donors) (Fig. 3A and Table 2). This pattern of
reactivity was conﬁrmed when the monoclonal antibodies
were used to detect surface-expressed 3D7-VAR2CSA
domains on transfected Jurkat cells in a ﬂow cytometry
assay (Fig. 3A). Competition ELISA to examine the
epitopes recognized by the DBL3-X and DBL5-e-reactive
monoclonal antibodies showed that the DBL3-X-reactive
antibodies PAM2.8 and PAM6.1 targeted antigenically dis-
tinct epitopes (Fig. 3B), while two (PAM3.10 and PAM7.5)
of the DBL5-e-reactive antibodies appeared to target
neighbouring or overlapping epitopes (Fig. 3C).
Human VAR2CSA DBL3-X-speciﬁc monoclonal IgG
antibodies recognize epitopes that vary between
parasite isolates
The pattern of monoclonal antibody recognition of IEs
varied between parasite isolates. This is consistent with
the ﬁnding that the var2csa sequence is composed of
conserved stretches separated by stretches with sub-
stantial interclonal diversity (Duffy et al., 2006a; Trimnell
et al., 2006), and the prediction that B-cell epitopes in
VAR2CSA DBL3-X locate mainly to polymorphic,
surface-exposed parts of VAR2CSA (Dahlbäck et al.,
2006). We therefore cloned and sequenced 43
VAR2CSA DBL3-X domains from placental parasite iso-
lates. A subset of 29 of these domains selected to rep-
resent the overall VAR2CSA DBL3-X diversity was
expressed as Baculovirus recombinant proteins and
used in ELISA to test the speciﬁcity of the three
VAR2CSA DBL3-X-speciﬁc monoclonals. The PAM2.8
antibody reacted with 25, PAM6.1 with eight and PAM8.1
with 20 of the domain variants (Fig. 4A). A multiple
sequence alignment of all the proteins indicated that the
main difference between the PAM8.1-negative and
-positive proteins was a C-terminal 16-amino-acid
stretch that maps to a polymorphic region of 3D7-
VAR2CSA DBL3-X, which is predicted to be a surface-
exposed loop (Dahlbäck et al., 2006) (Fig. 4B). Residues
in this region either were deleted in the PAM8.1-negative
proteins or had a different amino acid composition com-
pared with the PAM8.1-positive variants (Fig. 4A). To
substantiate this possibility we constructed a chimeric
protein where the 16-amino-acid stretch from a PAM8.1-
positive domain variant (FCR3) was transferred to the
corresponding site in a PAM8.1-negative variant lacking
this sequence (3D7) (Fig. 4A, bottom). The recombinant
proteins corresponding to the unmodiﬁed FCR3
sequence and the chimeric construct both tested posi-
tive in Western blots probed with PAM8.1, in contrast to
the recombinant protein representing the authentic 3D7
sequence (Fig. 4C), thus conﬁrming the predicted posi-
tion of the PAM8.1 epitope. It was not possible to predict
the exact targets of PAM2.8 and PAM6.1 by multiple
alignments of the primary sequences.
Human monoclonal antibody PAM1.4 effectively selects
for expression of VSAPAM and increased transcription of
VAR2CSA
PAM1.4 stained VSAPAM-expressing IEs, but did not yield
any bands in Western blots, and did not react with any of
the VAR2CSA constructs when tested in ELISA or by ﬂow
cytometry (Tables 1 and 2). These observations are com-
patible with recognition by this antibody of a conforma-
tional epitope in VAR2CSA, but also with recognition of an
unidentiﬁed non-VAR2CSA PAM-speciﬁc IE surface
antigen. To address this question, we tested the ability of
PAM1.4 to enrich VSAPAM-expressing IEs in two parasite
lines (EJ24 and EJ27) initially expressing non-PAM-type
VSA and only marginally recognized by PAM1.4 (Fig. 5A
and B, and data not shown). Although both isolates were
originally obtained from the peripheral blood of pregnant
women, and thus expected to express VSAPAM, isolates
expressing non-PAM VSA– such as EJ24 and EJ27 – are
occasionally found (Ofori et al., 2003, and our unpub-
lished data). Remarkably, a single round of PAM1.4 anti-
body selection of EJ27 (Fig. 5C and D) and EJ24 (data
not shown) resulted in rapid emergence of IEs uniformly
recognized by PAM1.4 and expressing VSAPAM (Fig. 5C
and D). Quantitative real-time polymerase chain reaction
(PCR) analysis of the isolates showed increases in
var2csa transcription in response to the selection for
PAM1.4 reactivity (EJ24: twofold and EJ27: 30-fold). In
addition, EJ24 acquired reactivity with the VAR2CSA-
speciﬁc antibodies PAM2.8, PAM3.10, PAM6.1 and
PAM7.5 following selection for PAM1.4 reactivity
(Table 1). EJ27 did not acquire additional reactivity follow-
ing PAM1.4 selection, probably because of interclonal
Fig. 4. PAM8.1 recognition of VAR2CSA DBL3-X.
A. Amino acid sequence in the region of the domain where interclonal variation affected PAM8.1 recognition of Baculovirus-produced DBL3-X
constructs from 29 genetically distinct P. falciparum isolates, including the sequence of a chimeric protein constructed to add PAM8.1 reactivity
to the otherwise PAM8.1-negative 3D7 VAR2CSA DBL3-X sequence.
B. Structural model of the 3D7 DBL3-X domain. The predicted loop region where parasite isolates recognized by PAM8.1 have a deﬁnite
insertion compared with 3D7 is shown in red. The 3D7 residues ﬂanking the insert, G1474 and Q1475 (positions 26 and 39 in A), are
highlighted in black.
C. Western blots of recombinant 3D7- and FCR3-speciﬁc VAR2CSA DBL3-X constructs, and of the above-mentioned chimeric construct,
probed with loading control antibody V5 (left) and PAM8.1 (right). MW, molecular weight.
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other monoclonal antibodies. Taken together, these ﬁnd-
ings are consistent with VAR2CSA being the antigenic
target of PAM1.4.
Concluding remarks
We have shown that it is possible to interrogate the
memory B-cell repertoire of malaria-immune donors to
estimate frequencies of P. falciparum-speciﬁc B cells,
and to isolate speciﬁc monoclonal antibodies with speci-
ﬁcity for the VSA repeatedly implicated as the main
targets of acquired protective immunity to malaria. We
have used this approach to demonstrate that PAM can
result in acquisition of high frequencies of B cells pro-
ducing IgG with speciﬁcity for VSAPAM, and in particular
VAR2CSA, strengthening previous evidence that these
antigen speciﬁcities are critically important in acquired
protective immunity to PAM. We furthermore show that
VSAPAM-speciﬁc memory B cells acquired in response to
PAM primarily target polymorphic, conformation-
dependent epitopes that are reproduced by Baculovirus-
produced recombinant antigen constructs. Our data thus
underscore the importance of VAR2CSA in acquired
AB
C
FITC
FITC
D
Fig. 5. PAM1.4 selection of parasite line EJ27.
A. Pre-selection reactivity of monoclonal antibody PAM1.4 (heavy line) and negative control monoclonal antibody (thin line) with the surface of
EJ27-IEs.
B. Pre-selection non-PAM VSA-type recognition pattern of EJ27 by IgG in plasma from P. falciparum-exposed men and women and in plasma
from non-exposed adults.
C. Reactivity of PAM1.4 antibody (heavy line) and negative control antibody (thin line) with the surface of erythrocytes infected by the EJ27
after a single round of selection for reactivity with PAM1.4.
D. Post-selection VSAPAM-type recognition pattern of EJ27 by IgG in plasma from P. falciparum-exposed men and women and in plasma from
non-exposed adults.
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and elsewhere (Dahlbäck et al., 2006) also suggest that
var2csa diversity (Duffy et al., 2006a; Trimnell et al.,
2006) is driven by protective immunity to PAM, a situa-
tion that may complicate development of VAR2CSA-
based vaccines against PAM (Beeson et al., 2006). IE
adhesion to CSA, which is thought to be a critical
element in the pathogenesis of PAM (Fried and Duffy,
1996), is mediated by VAR2CSA as documented by
recent knockout studies (Viebig et al., 2005; Duffy et al.,
2006b), and several CSA-adhesive domains have been
identiﬁed in the antigen (Gamain et al., 2005). Recent
studies in mice suggest that vaccination can elicit
broadly reactive antibodies that can block VAR2CSA-
dependent IE adhesion to CSA (Gamain et al., 2004; Bir
et al., 2006), but whether such antibodies are ever pro-
duced in humans in response to PAM, how clinically rel-
evant they are, and whether they can be induced by
vaccination in humans remain unanswered questions.
Understandably, present research is highly focused on
the identiﬁcation of functionally constrained epitopes in
these domains that are critical for IE adhesion to CSA
and of intergenomically conserved epitopes that may
serve as targets of antibodies interfering with it. Human
monoclonal antibodies appear to be a powerful tool in
this research.
Experimental procedures
Parasite cultivation and selection for infected
erythrocyte surface expression of VSAPAM
All P. falciparum parasites used in this study were grown in
0
+ erythrocytes (Cranmer et al., 1997). 3D7, FCR3 and
NF54 are long-term in vitro cultured lines. All expressed
non-PAM-type VSA, meaning that intact IEs were recog-
nized to a similar extent by IgG in the plasma of
P. falciparum-exposed men and sympatric, multigravid
women in a ﬂow cytometry assay of VSA expression (Fig. 1,
3D7-SM) (Staalsoe et al., 1999). The 3D7 subline 3D7-SM
was derived by human plasma antibody selection of 3D7 for
expression of non-PAM-type PfEMP1 associated with
severe malaria in children as described (Staalsoe et al.,
2003; Jensen et al., 2004). The VSAPAM-expressing subline
3D7-BeWo was selected by repeated panning of IEs on the
choriocarcinoma line BeWo as described elsewhere (Haase
et al., 2006). Parasites were considered as expressing
VSAPAM if the level of labelling of intact IEs by IgG in a panel
of plasma samples from P. falciparum-exposed multigravid
women was signiﬁcantly higher than the level in plasma
from sympatric men (Fig. 1, FCR3-CSA and NF54-
VAR2CSA). The characteristics of the plasma IgG recogni-
tion pattern of VSAPAM and non-PAM-type VSA have been
documented in detail elsewhere (Ricke et al., 2000; Staal-
soe et al., 2001). Sublines of FCR3 and NF54 (FCR3-CSA
and NF54-CSA respectively) were selected for expression
of VSAPAM by repeated panning of IEs on CSA in vitro (Fried
and Duffy, 1996; Ricke et al., 2000). NF54-CSA was further
selected for IE reactivity with rabbit antiserum speciﬁc for
VAR2CSA DBL5-e, resulting in subline NF54-VAR2CSA
(Salanti et al., 2004). Additional sublines of FCR3 (FCR3-
A745 and FCR3-CD36) expressing non-PAM VSA were
selected by repeated panning on CSA-negative CHO cells
(CHO-A745) and recombinant CD36, respectively, essen-
tially as described for BeWo and CSA selection. Isolates
EJ24 and EJ27 were obtained from the peripheral blood of
pregnant, P. falciparum-exposed women and adapted to in
vitro culture (Giha et al., 1999). Both isolates were selected
for expression of VSA reacting with the human VSAPAM-
speciﬁc monoclonal antibody PAM1.4 (see below), essen-
tially as described (Staalsoe et al., 2003), but using Protein
A-coated magnetic microbeads, as VSAPAM-expressing IEs
are prone to non-speciﬁc labelling by second-step antisera
(Creasey et al., 2003; Rasti et al., 2006).
Memory B-cell immortalization and cloning
Peripheral blood mononuclear cells (PBMC) from
P. falciparum-exposed, recently pregnant multiparous women
were isolated and cryopreserved as described (Hviid et al.,
1993). At the day of use, PBMC were thawed and IgG
+
memory B cells were isolated using CD22 microbeads (Milte-
nyi) followed by cell sorting as described (Traggiai et al.,
2004). Cells were immortalized at 100 cells per well in mul-
tiple 96-well plates using EBV in the presence of CpG
ODN2006 (Microsynth, Switzerland) (Hartmann and Krieg,
2000) and irradiated PBMC as described (Traggiai et al.,
2004).
Antibody characterization by ﬂow cytometry,
immunoﬂuorescence microscopy and ELISA
Polyclonal B-cell culture supernatants were screened by ﬂow
cytometry (Staalsoe et al., 1999) for IgG reactivity with the
surface of intact, unﬁxed erythrocytes infected by FCR3-
CSA, NF54-VAR2CSA and 3D7-SM. VSAPAM-reactive B-cell
lines, selected on the basis of their rate of IgG synthesis and
growth rates, were cloned by limiting dilution as described
(Traggiai et al., 2004) and the selectivity of the human mono-
clonal antibodies produced by the clones for IEs expressing
VSAPAM was conﬁrmed as above. The reactivity of the anti-
bodies with the surface of wet-mounted antibody-labelled IEs
was further veriﬁed by immunoﬂuorescence microscopy,
using an LSM5 scanning microscope (Carl Zeiss MicroImag-
ing) (Salanti et al., 2004). The IgG subclass of all the human
monoclonal antibodies was determined by ELISAand veriﬁed
by ﬂow cytometry using isotype-speciﬁc antibodies (Meg-
nekou et al., 2005).
Antibody characterization by Western blotting
Parasite cultures were enriched for erythrocytes infected by
late trophozoite/schizont-stage parasites by exposure to a
strong magnetic ﬁeld (Paul et al., 1981; Staalsoe et al.,
1999). Protein extracts of puriﬁed IEs were prepared with 2%
SDS in PBS containing complete protease inhibitor (Roche,
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loading buffer and separated in pre-cast tris-acetate 5–8%
SDS gradient gels (Invitrogen, Tåstrup, Denmark) with tris-
acetate running buffer (Invitrogen), employing pre-stained
broad-range molecular weight markers (Bio-Rad, Herlev,
Denmark). The separated proteins were transferred to PVDF
membranes by wet blotting in transfer buffer containing 20%
isopropanol, 20 mM tris-acetate and 0.1% SDS, followed by
blocking with 5% skimmed-milk powder in TBS-T buffer.
Membranes were incubated with the human monoclonal anti-
bodies or a monoclonal mouse anti-exon 2 antibody, followed
by incubation with a secondary anti-human or anti-mouse
AP-conjugated antibody (Sigma, MO, USA) and developed
using a 5-bromo-4-chloro-3-indoyl phosphate and nitroblue
tetrazolium solution (Sigma). Baculovirus-produced proteins
and a pre-stained ProSieve protein marker (Cambrex) were
run on pre-cast 4–12% SDS gradient gels (Invitrogen,
Tåstrup, Denmark) with NuPage MOPS SDS running buffer
(Invitrogen). Proteins were transferred to a nitrocellulose
membrane by wet blotting using a buffer of 20% methanol,
25 mM Tris and 192 mM glycine. Following blocking in 5%
skimmed-milk powder in TBS-T buffer, membranes were
incubated for 1 h with either a 1:5000 dilution of horseradish
peroxidase-conjugated loading control antibody anti-V5
(R960-25, Invitrogen) or a 1:1000 dilution of PAM8.1. The
PAM8.1-probed membrane was further incubated with a
1:1000 dilution of a secondary anti-human IgG antibody
(P0214, Dako Cytomation). Membranes were developed
using 3-amino-9-ethyl-carbazole tablets dissolved in
acetone, 50 mM sodium acetate and 30% H2O2.
Recombinant VAR2CSA proteins
Regions of re-codonized 3D7-var2csa (PFL0030c) and
FCR3-var2csa covering the entire exon 1 were subcloned
into the pBAD-TOPO vector, transferred with the V5 and HIS
tag to the pAcGP67-A transfer vector (BD Biosciences), pro-
duced as recombinant proteins in Baculovirus-infected insect
cells, and puriﬁed as described (Salanti et al., 2004). We
have previously shown that Baculovirus-produced VAR2CSA
constructs are conformationally intact, as they induce produc-
tion of rabbit antisera reactive with native VAR2CSA on the
surface of IEs (Barfod et al., 2006). The following regions
(indicated by encoded amino acids numbers) were produced:
A: 0–446, E: 447–876, I: 877–1208, L: 1209–1572, P: 1573–
1980, T: 1981–2355, Z: 2356–2685. In addition, regions of
re-codonized 3D7-var2csa were cloned into the pDisplay
vector (Invitrogen) for surface expression in Jurkat cells
(below). The pDisplay vector supplies a signal sequence and
a trans-membrane domain for surface expression, and two
epitope tags (haemagglutinin and c-myc) for monitoring
protein expression. The following regions were expressed in
Jurkat cells (for details, see below): B: 0–449, C: 0–669, D:
443–870, F: 674–1253, G: 680–906, H: 680–1011, J: 1201–
1379, K: 1201–1579, M: 1258–1967, N: 1380–1579, O:
1559–1992, Q: 1776–2131, R: 1965–2666, S: 1981–2336, U:
1981–2524, V: 2147–2666, X: 2210–2666 and Y: 2317–2666.
Different variants of DBL3-X were cloned and produced as
described (Dahlbäck et al., 2006). For the cloning of the
chimeric construct composed of 5′ 3D7-VAR2CSA DBL3-X
and 3′ FCR3-VAR2CSA DBL3-X, we used the primers 5′:
cggaattcGATACAAATGGTGCCTGT and 3′: CATTTCTTT
TCATTCTTACCATTATTAGTGCA to generate the 3D7-
speciﬁc, and 5′: AAGAATGAAAAGAAATGTATTAATTC and
3′: atttgcggccgcATATACTGCTATAATCTCC to generate the
FCR3-speciﬁc part of the chimera. These primers amplify a
slightly smaller PCR product than the original primers used
for making the FCR3 and 3D7 DBL3-X constructs, and this is
reﬂected in the smaller molecular size of the chimeric
construct. The two PCR products were gel-puriﬁed and used
in a second PCR using the two outer primers to generate a
PCR product consisting of 5′ 3D7 and 3′ FCR3, with an EcoRI
site and a NotI site. The PCR product was cloned into a
modiﬁed pAcGP67-Avector (BD Biosciences) and expressed
in insect cells as described (Salanti et al., 2004).
ELISA
VSAPAM-reactive monoclonal IgG-containing supernatants
were tested in ELISA (Dodoo et al., 2000) for reactivity with
the recombinant VAR2CSAproteins produced in Baculovirus-
infected insect cells. In addition, the epitope speciﬁcities of
monoclonal antibodies targeting DBL3-X (PAM2.8 and
PAM6.1) and DBL5-e (PAM3.10, PAM5.2 and PAM7.5) were
analysed by competition ELISA. PAM3.10 and PAM6.1 were
puriﬁed on ÄktaXpress (GE Healthcare, Brøndby, Denmark)
using a HiTrap Protein G HP 1 ml column with subsequent
desalting on a HiPrep 26/10 desalting column (GE
Healthcare). Puriﬁed IgG was biotinylated using EZ-link
maleimide-PEO solid phase as described by the manufac-
turer (Pierce, Bonn, Germany). Microtitre plates (Nunc, Rosk-
ilde, Denmark) were coated with recombinant DBL3-X
(8.3 mgm l
-1) or DBL5-e (10.4 mgm l
-1) in PBS (1 h, 37°C).
After blocking of the plates, biotinylated PAM3.1-speciﬁc
IgG (0.72 mgm l
-1) or biotinylated PAM6.1-speciﬁc IgG
(2.5 mgm l
-1) and increasing concentrations of the competitor
monoclonal culture supernatants were added to triplicate
wells. PAM1.4 (unknown VSAPAM-speciﬁcity) and PAM2.8
(DBL3-X-speciﬁc) were added as negative controls to DBL3-
X-coated and DBL5-e-coated plates respectively. Bound
biotinylated IgG was detected by incubation (1 h, room tem-
perature) of wells with horseradish peroxidase-conjugated
streptavidin (1 mgm l
-1, 100 ml well
-1; Pierce, Bonn,
Germany).
Analysis of monoclonal IgG speciﬁcity by ﬂow cytometry
of var2csa-transfected Jurkat cells
The human T-cell line Jurkat (Gillis and Watson, 1980) was
cultured in RPMI 1640, supplemented with 25 mM HEPES
and L-glutamine (Gibco, Tåstrup, Denmark), 10% FCS,
100 IU ml
-1 penicillin and 100 mgm l
-1 streptomycin. Two
million cells were seeded into each well of a six-well plate and
transfected with 3–4 mg of plasmid DNA (see above) and 4 ml
of DMRIE-C transfection reagent (Invitrogen) according to
the manufacturer’s instructions. Within 48 h of transfection,
the cells were washed and re-suspended at 1 ¥ 10
6 ml
-1 in
PBS supplemented with 2% FCS. Cells (1 ¥ 10
5) were incu-
bated with human monoclonal antibodies or with a haemag-
glutinin mouse antibody for 30 min followed by two washes
and labelling by secondary FITC-conjugated anti-human IgG
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essentially as above.
Monoclonal antibody epitope mapping by recombinant
VAR2CSA DBL3-X constructs and in silico modelling
Recombinant VAR2CSA DBL3-X constructs from 29 geno-
typically distinct P. falciparum isolates were produced in
Baculovirus-infected insect cells and tested in ELISA essen-
tially as described above. The three-dimensional structure of
the 3D7-VAR2CSA DBL3-X sequence (PFL0030c, amino
acids 1217–1559) was modelled in silico as described else-
where (Dahlbäck et al., 2006). Brieﬂy, the crystal structure of
EBA-175 F1 (PDB code 1ZRO chain A) (Tolia et al., 2005),
which has 28% sequence identity to the 3D7-VAR2CSA
DBL3-X domain, was used as a template. The model was
evaluated with respect to locations of conserved cysteine
bridges and buried hydrophobic residues in the structures of
DBL domains from EBA-175 F1 and F2 (Tolia et al., 2005)
and Pk-a DBL (Singh et al., 2005).
Quantitative real-time PCR
Quantitative real-time PCR was performed on cDNA from
unselected and PAM1.4 antibody-selected isolates EJ24 and
EJ27 using a Rotorgene thermal cycler system (Corbett
Research, Cambridge, UK) and a primer set speciﬁc for a
highly conserved part of the var2csa DBL-4e domain, target-
ing all var2csa genes without bias (Salanti et al., 2003;
Tuikue Ndam et al., 2005). Selection-induced changes in
var2csa transcription were quantiﬁed as described (Salanti
et al., 2003).
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